Comorbidity Screening & Escalation SOP

What's inside

This standard operating procedure is fully drafted and structured, ready to brand and complete for your service. It covers:

• 1. Purpose
• 2. Scope
• 3. Definitions
• 4. Responsibilities
• 5. When screening is performed
• 6. Conditions to screen for, recommended tools and action thresholds
• 7. Physical health and cardiovascular screening before pharmacological treatment
• 8. Managing a positive screen
• 9. Escalation pathways and thresholds
• 10. Urgent risk and crisis management
• 11. Documentation
• 12. Communication with the GP and shared care
• 13. Remote and telehealth considerations
• 14. Training and competence
• 15. Audit and monitoring
• 16. Related documents
• 17. Document control and review

CQC fundamental standard

Legislation & standards it maps to

• NICE NG87 – Attention deficit hyperactivity disorder: diagnosis and management
• NICE CG133 – Self-harm (and NICE NG225 Self-harm: assessment, management and preventing recurrence)
• Health and Social Care Act 2008 (Regulated Activities) Regulations 2014, Regulation 12 (Safe care and treatment)
• CQC single assessment framework
• General Medical Council – Good medical practice (2024)
• Mental Health Act 1983 (as amended)
• Safeguarding Vulnerable Groups Act 2006
• Medicines and Healthcare products Regulatory Agency (MHRA) guidance on methylphenidate and cardiovascular safety
• British National Formulary (BNF) – central nervous system stimulants and ADHD

Who it applies to

All assessing and prescribing clinicians, clinical staff and [Clinical Lead] at [Organisation Name].

How it works

1. Buy securely with Stripe - instant, no VAT, no account needed.
2. Download your editable Word file from the link we email you straight away.
3. Complete the placeholders for your service, then have it approved before use.
4. Add the optional updates subscription and we keep it current as guidance changes.